ALMOTRIPTAN EG 12.5 mg, film-coated tablet 6 tablets
Active ingredients: Almotriptan, Almotriptan malate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet6 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ALMOTRIPTAN EG 12,5 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) polyamide aluminium PVC-Aluminium de 6 comprimé(s)
- Marketing authorisation holder
- EG LABO - LABORATOIRES EUROGENERICS
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Jan 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65724460CIP73002135CIP133400930021354Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MALATE D'ALMOTRIPTANcomprimé | 17,50 mg · un comprimé | SA |
| ALMOTRIPTANcomprimé | 12,50 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.